BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Alembic Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
533573
ISIN Demat
INE901L01018
Book Value (Rs)
304.2988178
NSE Symbol
APLLTD
Divident Yield %
1.24
Market Cap
(Rs In Cr.)
18,984
P/E (TTM)
18.63
EPS (TTM)
51.84
Face Value
(Rs)
2
Back
Alembic Pharmaceuticals consolidated net profit rises 12.11% in the June 2026 quarter
04-Aug-26   Hrs IST

Net profit of Alembic Pharmaceuticals rose 12.11% to Rs 173.07 crore in the quarter ended June 2026 as against Rs 154.38 crore during the previous quarter ended June 2025. Sales rose 25.66% to Rs 2149.77 crore in the quarter ended June 2026 as against Rs 1710.72 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales2149.771710.72 26
OPM %15.4416.42 -
PBDT319.57263.88 21
PBT221.86190.11 17
NP173.07154.38 12

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
BSE Delayed market data sourced at 5 minutes – www.bseindia.com
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)